These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 32478437)
1. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation. Grønbaek H; Møller HJ; Saliba F; Zeuzem S; Albillos A; Ariza X; Graupera I; Solà E; Amoros A; Pavesi M; Bossen L; Jalan R; Gines P; Arroyo V J Gastroenterol Hepatol; 2021 Jan; 36(1):240-248. PubMed ID: 32478437 [TBL] [Abstract][Full Text] [Related]
2. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF). Grønbæk H; Rødgaard-Hansen S; Aagaard NK; Arroyo V; Moestrup SK; Garcia E; Solà E; Domenicali M; Piano S; Vilstrup H; Møller HJ; J Hepatol; 2016 Apr; 64(4):813-22. PubMed ID: 26639396 [TBL] [Abstract][Full Text] [Related]
3. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients. Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718 [TBL] [Abstract][Full Text] [Related]
4. Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure. Alexopoulou A; Vasilieva L; Mani I; Agiasotelli D; Pantelidaki H; Dourakis SP Scand J Gastroenterol; 2017 Dec; 52(12):1385-1390. PubMed ID: 28851246 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. Jalan R; Saliba F; Pavesi M; Amoros A; Moreau R; Ginès P; Levesque E; Durand F; Angeli P; Caraceni P; Hopf C; Alessandria C; Rodriguez E; Solis-Muñoz P; Laleman W; Trebicka J; Zeuzem S; Gustot T; Mookerjee R; Elkrief L; Soriano G; Cordoba J; Morando F; Gerbes A; Agarwal B; Samuel D; Bernardi M; Arroyo V; J Hepatol; 2014 Nov; 61(5):1038-47. PubMed ID: 24950482 [TBL] [Abstract][Full Text] [Related]
6. Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome. Dhiman RK; Agrawal S; Gupta T; Duseja A; Chawla Y World J Gastroenterol; 2014 Oct; 20(40):14934-41. PubMed ID: 25356054 [TBL] [Abstract][Full Text] [Related]
7. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure. Li TP; Guan SH; Wang Q; Chen LW; Yang K; Zhang H World J Gastroenterol; 2019 Oct; 25(37):5667-5675. PubMed ID: 31602166 [TBL] [Abstract][Full Text] [Related]
8. Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis. Silva PE; Fayad L; Lazzarotto C; Ronsoni MF; Bazzo ML; Colombo BS; Dantas-Correa EB; Narciso-Schiavon JL; Schiavon LL Liver Int; 2015 May; 35(5):1516-23. PubMed ID: 24840673 [TBL] [Abstract][Full Text] [Related]
9. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment. Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015 [TBL] [Abstract][Full Text] [Related]
10. Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation. Rainer F; Horvath A; Sandahl TD; Leber B; Schmerboeck B; Blesl A; Groselj-Strele A; Stauber RE; Fickert P; Stiegler P; Møller HJ; Grønbaek H; Stadlbauer V Aliment Pharmacol Ther; 2018 Mar; 47(5):657-664. PubMed ID: 29266346 [TBL] [Abstract][Full Text] [Related]
11. The Role of the CLIF-C OF and the 2016 MELD in Prognosis of Cirrhosis with and without Acute-on-Chronic Liver Failure. Perdigoto DN; Figueiredo P; Tomé L Ann Hepatol; 2019; 18(1):48-57. PubMed ID: 31113608 [TBL] [Abstract][Full Text] [Related]
12. Clinical Implication of Plasma CD163 in Patients With Acute-on-Chronic Liver Failure. Raszeja-Wyszomirska J; Niewiński G; Graczyńska A; Morawiec S; Janik MK; Kornasiewicz O Transplant Proc; 2022 May; 54(4):1011-1016. PubMed ID: 35523597 [TBL] [Abstract][Full Text] [Related]
13. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival. Kerbert AJC; Verspaget HW; Navarro ÀA; Jalan R; Solà E; Benten D; Durand F; Ginès P; van der Reijden JJ; van Hoek B; Coenraad MJ; Crit Care; 2017 Dec; 21(1):321. PubMed ID: 29268760 [TBL] [Abstract][Full Text] [Related]
14. Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. Bernsmeier C; Cavazza A; Fatourou EM; Theocharidou E; Akintimehin A; Baumgartner B; Dhar A; Auzinger G; Thursz M; Bernal W; Wendon JA; Karvellas CJ; Antoniades CG; McPhail MJW Aliment Pharmacol Ther; 2020 Sep; 52(5):855-865. PubMed ID: 32683724 [TBL] [Abstract][Full Text] [Related]
15. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. Jalan R; Pavesi M; Saliba F; Amorós A; Fernandez J; Holland-Fischer P; Sawhney R; Mookerjee R; Caraceni P; Moreau R; Ginès P; Durand F; Angeli P; Alessandria C; Laleman W; Trebicka J; Samuel D; Zeuzem S; Gustot T; Gerbes AL; Wendon J; Bernardi M; Arroyo V; J Hepatol; 2015 Apr; 62(4):831-40. PubMed ID: 25463539 [TBL] [Abstract][Full Text] [Related]
16. Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. Li H; Chen LY; Zhang NN; Li ST; Zeng B; Pavesi M; Amorós À; Mookerjee RP; Xia Q; Xue F; Ma X; Hua J; Sheng L; Qiu DK; Xie Q; Foster GR; Dusheiko G; Moreau R; Gines P; Arroyo V; Jalan R Sci Rep; 2016 May; 6():25487. PubMed ID: 27146801 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure. Gao F; Sun L; Ye X; Liu Y; Liu H; Geng M; Li X; Yang X; Li Y; Wang R; Chen J; Wan G; Jiang Y; Wang X Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):669-678. PubMed ID: 28195876 [TBL] [Abstract][Full Text] [Related]
19. Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study. Andersen ES; Rødgaard-Hansen S; Moessner B; Christensen PB; Møller HJ; Weis N Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):117-22. PubMed ID: 24424890 [TBL] [Abstract][Full Text] [Related]
20. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity. Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]